Frequency Therapeutics (FREQ) shares plunge 73% after FX-322's four-dose regime fails to improve hearing loss
March 23 2021 - 8:42AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Frequency Therapeutics (NASDAQ:FREQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Frequency Therapeutics (NASDAQ:FREQ)
Historical Stock Chart
From Apr 2023 to Apr 2024